APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pefloxacin Mesylate for Injection

Compare research editions
View pricing & licenses

Selected research

Industry Research

Pefloxacin Mesylate for Injection Industry Research Report 2026

27 December 2025143 pages

Choose your research edition.

Industry ResearchPefloxacin Mesylate for Injection Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Pefloxacin Mesylate for Injection Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Pefloxacin Mesylate for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pefloxacin Mesylate for Injection Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Pefloxacin Mesylate for Injection Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Pefloxacin Mesylate for Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Pefloxacin Mesylate for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Pefloxacin Mesylate for Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Pefloxacin Mesylate for Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Pefloxacin Mesylate for Injection include Chengdu Tiantaishan Pharmaceutical Co., Ltd., Furen Pharmaceutical Group Co., Ltd., Guangdong Xinghao Pharmaceutical Co., Ltd., Harbin Sanlian Pharmaceutical Co., Ltd., Harbin Songhe Pharmaceutical Co., Ltd., Haikou Qili Pharmaceutical Co., Ltd., Hainan General Kangli Pharmaceutical Co., Ltd., Hainan Zhuotai Pharmaceutical Co., Ltd. and Hubei Wushi Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Pefloxacin Mesylate for Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pefloxacin Mesylate for Injection Market by Company

Chengdu Tiantaishan Pharmaceutical Co., Ltd.

Furen Pharmaceutical Group Co., Ltd.

Guangdong Xinghao Pharmaceutical Co., Ltd.

Harbin Sanlian Pharmaceutical Co., Ltd.

Harbin Songhe Pharmaceutical Co., Ltd.

Haikou Qili Pharmaceutical Co., Ltd.

Hainan General Kangli Pharmaceutical Co., Ltd.

Hainan Zhuotai Pharmaceutical Co., Ltd.

Hubei Wushi Pharmaceutical Co., Ltd.

Hunan Wuzhoutong Pharmaceutical Co., Ltd.

Hunan Yige Pharmaceutical Co., Ltd.

Jiangxi Gannan Haixin Pharmaceutical Co., Ltd.

Jincheng Haisi Pharmaceutical Co., Ltd.

Ruiyang Pharmaceutical Co., Ltd.

Shandong Phoenix Pharmaceutical Co., Ltd.

Sichuan Sanxingdui Pharmaceutical Co., Ltd.

Yantai Dongcheng North Pharmaceutical Co., Ltd.

Zhejiang Beide Pharmaceutical Co., Ltd.

Zhejiang Asia Pacific Pharmaceutical Co., Ltd.

Zhejiang Zuoli Pharmaceutical Co., Ltd.

Pefloxacin Mesylate for Injection Segment by Type

0.2g/Piece

0.4g/Piece

Pefloxacin Mesylate for Injection Segment by Application

Physical Pharmacies

Clinic

Other

Pefloxacin Mesylate for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pefloxacin Mesylate for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pefloxacin Mesylate for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pefloxacin Mesylate for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Pefloxacin Mesylate for Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Pefloxacin Mesylate for Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Pefloxacin Mesylate for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pefloxacin Mesylate for Injection Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Pefloxacin Mesylate for Injection Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Pefloxacin Mesylate for Injection Sales Market Share by Manufacturers (2021-2026) Table 8. Global Pefloxacin Mesylate for Injection Revenue of Manufacturers (2021-2026) Table 9. Global Pefloxacin Mesylate for Injection Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Pefloxacin Mesylate for Injection Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Pefloxacin Mesylate for Injection Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Pefloxacin Mesylate for Injection, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Pefloxacin Mesylate for Injection, Product Type & Application Table 14. Global Pefloxacin Mesylate for Injection Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Pefloxacin Mesylate for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Company Information Table 19. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Business Overview Table 20. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 22. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Recent Developments Table 23. Furen Pharmaceutical Group Co., Ltd. Company Information Table 24. Furen Pharmaceutical Group Co., Ltd. Business Overview Table 25. Furen Pharmaceutical Group Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Furen Pharmaceutical Group Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 27. Furen Pharmaceutical Group Co., Ltd. Recent Developments Table 28. Guangdong Xinghao Pharmaceutical Co., Ltd. Company Information Table 29. Guangdong Xinghao Pharmaceutical Co., Ltd. Business Overview Table 30. Guangdong Xinghao Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Guangdong Xinghao Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 32. Guangdong Xinghao Pharmaceutical Co., Ltd. Recent Developments Table 33. Harbin Sanlian Pharmaceutical Co., Ltd. Company Information Table 34. Harbin Sanlian Pharmaceutical Co., Ltd. Business Overview Table 35. Harbin Sanlian Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Harbin Sanlian Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 37. Harbin Sanlian Pharmaceutical Co., Ltd. Recent Developments Table 38. Harbin Songhe Pharmaceutical Co., Ltd. Company Information Table 39. Harbin Songhe Pharmaceutical Co., Ltd. Business Overview Table 40. Harbin Songhe Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Harbin Songhe Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 42. Harbin Songhe Pharmaceutical Co., Ltd. Recent Developments Table 43. Haikou Qili Pharmaceutical Co., Ltd. Company Information Table 44. Haikou Qili Pharmaceutical Co., Ltd. Business Overview Table 45. Haikou Qili Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Haikou Qili Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 47. Haikou Qili Pharmaceutical Co., Ltd. Recent Developments Table 48. Hainan General Kangli Pharmaceutical Co., Ltd. Company Information Table 49. Hainan General Kangli Pharmaceutical Co., Ltd. Business Overview Table 50. Hainan General Kangli Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Hainan General Kangli Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 52. Hainan General Kangli Pharmaceutical Co., Ltd. Recent Developments Table 53. Hainan Zhuotai Pharmaceutical Co., Ltd. Company Information Table 54. Hainan Zhuotai Pharmaceutical Co., Ltd. Business Overview Table 55. Hainan Zhuotai Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Hainan Zhuotai Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 57. Hainan Zhuotai Pharmaceutical Co., Ltd. Recent Developments Table 58. Hubei Wushi Pharmaceutical Co., Ltd. Company Information Table 59. Hubei Wushi Pharmaceutical Co., Ltd. Business Overview Table 60. Hubei Wushi Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Hubei Wushi Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 62. Hubei Wushi Pharmaceutical Co., Ltd. Recent Developments Table 63. Hunan Wuzhoutong Pharmaceutical Co., Ltd. Company Information Table 64. Hunan Wuzhoutong Pharmaceutical Co., Ltd. Business Overview Table 65. Hunan Wuzhoutong Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Hunan Wuzhoutong Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 67. Hunan Wuzhoutong Pharmaceutical Co., Ltd. Recent Developments Table 68. Hunan Yige Pharmaceutical Co., Ltd. Company Information Table 69. Hunan Yige Pharmaceutical Co., Ltd. Business Overview Table 70. Hunan Yige Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Hunan Yige Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 72. Hunan Yige Pharmaceutical Co., Ltd. Recent Developments Table 73. Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. Company Information Table 74. Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. Business Overview Table 75. Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 77. Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. Recent Developments Table 78. Jincheng Haisi Pharmaceutical Co., Ltd. Company Information Table 79. Jincheng Haisi Pharmaceutical Co., Ltd. Business Overview Table 80. Jincheng Haisi Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Jincheng Haisi Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 82. Jincheng Haisi Pharmaceutical Co., Ltd. Recent Developments Table 83. Ruiyang Pharmaceutical Co., Ltd. Company Information Table 84. Ruiyang Pharmaceutical Co., Ltd. Business Overview Table 85. Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 87. Ruiyang Pharmaceutical Co., Ltd. Recent Developments Table 88. Shandong Phoenix Pharmaceutical Co., Ltd. Company Information Table 89. Shandong Phoenix Pharmaceutical Co., Ltd. Business Overview Table 90. Shandong Phoenix Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Shandong Phoenix Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 92. Shandong Phoenix Pharmaceutical Co., Ltd. Recent Developments Table 93. Sichuan Sanxingdui Pharmaceutical Co., Ltd. Company Information Table 94. Sichuan Sanxingdui Pharmaceutical Co., Ltd. Business Overview Table 95. Sichuan Sanxingdui Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Sichuan Sanxingdui Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 97. Sichuan Sanxingdui Pharmaceutical Co., Ltd. Recent Developments Table 98. Yantai Dongcheng North Pharmaceutical Co., Ltd. Company Information Table 99. Yantai Dongcheng North Pharmaceutical Co., Ltd. Business Overview Table 100. Yantai Dongcheng North Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Yantai Dongcheng North Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 102. Yantai Dongcheng North Pharmaceutical Co., Ltd. Recent Developments Table 103. Zhejiang Beide Pharmaceutical Co., Ltd. Company Information Table 104. Zhejiang Beide Pharmaceutical Co., Ltd. Business Overview Table 105. Zhejiang Beide Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Zhejiang Beide Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 107. Zhejiang Beide Pharmaceutical Co., Ltd. Recent Developments Table 108. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Company Information Table 109. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Business Overview Table 110. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 112. Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Recent Developments Table 113. Zhejiang Zuoli Pharmaceutical Co., Ltd. Company Information Table 114. Zhejiang Zuoli Pharmaceutical Co., Ltd. Business Overview Table 115. Zhejiang Zuoli Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Zhejiang Zuoli Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio Table 117. Zhejiang Zuoli Pharmaceutical Co., Ltd. Recent Developments Table 118. Global Pefloxacin Mesylate for Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 119. Global Pefloxacin Mesylate for Injection Sales by Region (2021-2026) & (K Units) Table 120. Global Pefloxacin Mesylate for Injection Sales Market Share by Region (2021-2026) Table 121. Global Pefloxacin Mesylate for Injection Sales by Region (2027-2032) & (K Units) Table 122. Global Pefloxacin Mesylate for Injection Sales Market Share by Region (2027-2032) Table 123. Global Pefloxacin Mesylate for Injection Revenue by Region (2021-2026) & (US$ Million) Table 124. Global Pefloxacin Mesylate for Injection Revenue Market Share by Region (2021-2026) Table 125. Global Pefloxacin Mesylate for Injection Revenue by Region (2027-2032) & (US$ Million) Table 126. Global Pefloxacin Mesylate for Injection Revenue Market Share by Region (2027-2032) Table 127. North America Pefloxacin Mesylate for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. North America Pefloxacin Mesylate for Injection Sales by Country (2021-2026) & (K Units) Table 129. North America Pefloxacin Mesylate for Injection Sales by Country (2027-2032) & (K Units) Table 130. North America Pefloxacin Mesylate for Injection Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Pefloxacin Mesylate for Injection Revenue by Country (2027-2032) & (US$ Million) Table 132. Europe Pefloxacin Mesylate for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Europe Pefloxacin Mesylate for Injection Sales by Country (2021-2026) & (K Units) Table 134. Europe Pefloxacin Mesylate for Injection Sales by Country (2027-2032) & (K Units) Table 135. Europe Pefloxacin Mesylate for Injection Revenue by Country (2021-2026) & (US$ Million) Table 136. Europe Pefloxacin Mesylate for Injection Revenue by Country (2027-2032) & (US$ Million) Table 137. Asia Pacific Pefloxacin Mesylate for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Asia Pacific Pefloxacin Mesylate for Injection Sales by Country (2021-2026) & (K Units) Table 139. Asia Pacific Pefloxacin Mesylate for Injection Sales by Country (2027-2032) & (K Units) Table 140. Asia Pacific Pefloxacin Mesylate for Injection Revenue by Country (2021-2026) & (US$ Million) Table 141. Asia Pacific Pefloxacin Mesylate for Injection Revenue by Country (2027-2032) & (US$ Million) Table 142. South America Pefloxacin Mesylate for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. South America Pefloxacin Mesylate for Injection Sales by Country (2021-2026) & (K Units) Table 144. South America Pefloxacin Mesylate for Injection Sales by Country (2027-2032) & (K Units) Table 145. South America Pefloxacin Mesylate for Injection Revenue by Country (2021-2026) & (US$ Million) Table 146. South America Pefloxacin Mesylate for Injection Revenue by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Pefloxacin Mesylate for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Middle East and Africa Pefloxacin Mesylate for Injection Sales by Country (2021-2026) & (K Units) Table 149. Middle East and Africa Pefloxacin Mesylate for Injection Sales by Country (2027-2032) & (K Units) Table 150. Middle East and Africa Pefloxacin Mesylate for Injection Revenue by Country (2021-2026) & (US$ Million) Table 151. Middle East and Africa Pefloxacin Mesylate for Injection Revenue by Country (2027-2032) & (US$ Million) Table 152. Global Pefloxacin Mesylate for Injection Sales by Type (2021-2026) & (K Units) Table 153. Global Pefloxacin Mesylate for Injection Sales by Type (2027-2032) & (K Units) Table 154. Global Pefloxacin Mesylate for Injection Sales Market Share by Type (2021-2026) Table 155. Global Pefloxacin Mesylate for Injection Sales Market Share by Type (2027-2032) Table 156. Global Pefloxacin Mesylate for Injection Revenue by Type (2021-2026) & (US$ Million) Table 157. Global Pefloxacin Mesylate for Injection Revenue by Type (2027-2032) & (US$ Million) Table 158. Global Pefloxacin Mesylate for Injection Revenue Market Share by Type (2021-2026) Table 159. Global Pefloxacin Mesylate for Injection Revenue Market Share by Type (2027-2032) Table 160. Global Pefloxacin Mesylate for Injection Price by Type (2021-2026) & (US$/Unit) Table 161. Global Pefloxacin Mesylate for Injection Price by Type (2027-2032) & (US$/Unit) Table 162. Global Pefloxacin Mesylate for Injection Sales by Application (2021-2026) & (K Units) Table 163. Global Pefloxacin Mesylate for Injection Sales by Application (2027-2032) & (K Units) Table 164. Global Pefloxacin Mesylate for Injection Sales Market Share by Application (2021-2026) Table 165. Global Pefloxacin Mesylate for Injection Sales Market Share by Application (2027-2032) Table 166. Global Pefloxacin Mesylate for Injection Revenue by Application (2021-2026) & (US$ Million) Table 167. Global Pefloxacin Mesylate for Injection Revenue by Application (2027-2032) & (US$ Million) Table 168. Global Pefloxacin Mesylate for Injection Revenue Market Share by Application (2021-2026) Table 169. Global Pefloxacin Mesylate for Injection Revenue Market Share by Application (2027-2032) Table 170. Global Pefloxacin Mesylate for Injection Price by Application (2021-2026) & (US$/Unit) Table 171. Global Pefloxacin Mesylate for Injection Price by Application (2027-2032) & (US$/Unit) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Pefloxacin Mesylate for Injection Distributors List Table 175. Pefloxacin Mesylate for Injection Customers List Table 176. Pefloxacin Mesylate for Injection Industry Trends Table 177. Pefloxacin Mesylate for Injection Industry Drivers Table 178. Pefloxacin Mesylate for Injection Industry Restraints Table 179. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pefloxacin Mesylate for Injection Product Image Figure 5. Global Pefloxacin Mesylate for Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Pefloxacin Mesylate for Injection Market Size (2021-2032) & (US$ Million) Figure 7. Global Pefloxacin Mesylate for Injection Sales (2021-2032) & (K Units) Figure 8. Global Pefloxacin Mesylate for Injection Average Price (US$/Unit) & (2021-2032) Figure 9. 0.2g/Piece Product Image Figure 10. 0.4g/Piece Product Image Figure 11. Physical Pharmacies Product Image Figure 12. Clinic Product Image Figure 13. Other Product Image Figure 14. Global Pefloxacin Mesylate for Injection Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Pefloxacin Mesylate for Injection, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Pefloxacin Mesylate for Injection Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Pefloxacin Mesylate for Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Pefloxacin Mesylate for Injection Sales by Region in 2025 Figure 20. Global Pefloxacin Mesylate for Injection Revenue by Region in 2025 Figure 21. North America Pefloxacin Mesylate for Injection Market Size by Country in 2025 Figure 22. North America Pefloxacin Mesylate for Injection Sales Market Share by Country (2021-2032) Figure 23. North America Pefloxacin Mesylate for Injection Revenue Market Share by Country (2021-2032) Figure 24. United States Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Pefloxacin Mesylate for Injection Market Size by Country in 2025 Figure 28. Europe Pefloxacin Mesylate for Injection Sales Market Share by Country (2021-2032) Figure 29. Europe Pefloxacin Mesylate for Injection Revenue Market Share by Country (2021-2032) Figure 30. Germany Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Pefloxacin Mesylate for Injection Market Size by Country in 2025 Figure 41. Asia Pacific Pefloxacin Mesylate for Injection Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Pefloxacin Mesylate for Injection Revenue Market Share by Country (2021-2032) Figure 43. China Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Pefloxacin Mesylate for Injection Market Size by Country in 2025 Figure 52. South America Pefloxacin Mesylate for Injection Sales Market Share by Country (2021-2032) Figure 53. South America Pefloxacin Mesylate for Injection Revenue Market Share by Country (2021-2032) Figure 54. Brazil Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Pefloxacin Mesylate for Injection Market Size by Country in 2025 Figure 58. Middle East and Africa Pefloxacin Mesylate for Injection Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Pefloxacin Mesylate for Injection Revenue Market Share by Country (2021-2032) Figure 60. Egypt Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Pefloxacin Mesylate for Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Pefloxacin Mesylate for Injection Sales Market Share by Type (2021-2032) Figure 66. Global Pefloxacin Mesylate for Injection Revenue Market Share by Type (2021-2032) Figure 67. Global Pefloxacin Mesylate for Injection Price (US$/Unit) by Type (2021-2032) Figure 68. Global Pefloxacin Mesylate for Injection Sales Market Share by Application (2021-2032) Figure 69. Global Pefloxacin Mesylate for Injection Revenue Market Share by Application (2021-2032) Figure 70. Global Pefloxacin Mesylate for Injection Price (US$/Unit) by Application (2021-2032) Figure 71. Pefloxacin Mesylate for Injection Value Chain Figure 72. Pefloxacin Mesylate for Injection Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Pefloxacin Mesylate for Injection Industry Opportunities and Challenges

Scope & coverage.

Types
  • 0.2g/Piece
  • 0.4g/Piece
Applications
  • Physical Pharmacies
  • Clinic
  • Other
Companies covered
  • Chengdu Tiantaishan Pharmaceutical Co., Ltd.
  • Furen Pharmaceutical Group Co., Ltd.
  • Guangdong Xinghao Pharmaceutical Co., Ltd.
  • Harbin Sanlian Pharmaceutical Co., Ltd.
  • Harbin Songhe Pharmaceutical Co., Ltd.
  • Haikou Qili Pharmaceutical Co., Ltd.
  • Hainan General Kangli Pharmaceutical Co., Ltd.
  • Hainan Zhuotai Pharmaceutical Co., Ltd.
  • Hubei Wushi Pharmaceutical Co., Ltd.
  • Hunan Wuzhoutong Pharmaceutical Co., Ltd.
  • Hunan Yige Pharmaceutical Co., Ltd.
  • Jiangxi Gannan Haixin Pharmaceutical Co., Ltd.
  • Jincheng Haisi Pharmaceutical Co., Ltd.
  • Ruiyang Pharmaceutical Co., Ltd.
  • Shandong Phoenix Pharmaceutical Co., Ltd.
  • Sichuan Sanxingdui Pharmaceutical Co., Ltd.
  • Yantai Dongcheng North Pharmaceutical Co., Ltd.
  • Zhejiang Beide Pharmaceutical Co., Ltd.
  • Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
  • Zhejiang Zuoli Pharmaceutical Co., Ltd.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Pefloxacin Mesylate for Injection Market Size (2021-2032)
  4. 2.2.2 Global Pefloxacin Mesylate for Injection Sales (2021-2032)
  5. 2.2.3 Global Pefloxacin Mesylate for Injection Market Average Price (2021-2032)
  6. 2.3 Pefloxacin Mesylate for Injection by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 0.2g/Piece
  9. 2.3.3 0.4g/Piece
  10. 2.4 Pefloxacin Mesylate for Injection by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Physical Pharmacies
  13. 2.4.3 Clinic
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Pefloxacin Mesylate for Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Pefloxacin Mesylate for Injection Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Pefloxacin Mesylate for Injection Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Pefloxacin Mesylate for Injection Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Pefloxacin Mesylate for Injection Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Pefloxacin Mesylate for Injection, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Pefloxacin Mesylate for Injection, Product Type & Application
  8. 3.8 Global Manufacturers of Pefloxacin Mesylate for Injection, Established Date
  9. 3.9 Global Pefloxacin Mesylate for Injection Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Chengdu Tiantaishan Pharmaceutical Co., Ltd.
  2. 4.1.1 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Company Information
  3. 4.1.2 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Business Overview
  4. 4.1.3 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  6. 4.1.5 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Recent Developments
  7. 4.2 Furen Pharmaceutical Group Co., Ltd.
  8. 4.2.1 Furen Pharmaceutical Group Co., Ltd. Company Information
  9. 4.2.2 Furen Pharmaceutical Group Co., Ltd. Business Overview
  10. 4.2.3 Furen Pharmaceutical Group Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Furen Pharmaceutical Group Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  12. 4.2.5 Furen Pharmaceutical Group Co., Ltd. Recent Developments
  13. 4.3 Guangdong Xinghao Pharmaceutical Co., Ltd.
  14. 4.3.1 Guangdong Xinghao Pharmaceutical Co., Ltd. Company Information
  15. 4.3.2 Guangdong Xinghao Pharmaceutical Co., Ltd. Business Overview
  16. 4.3.3 Guangdong Xinghao Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Guangdong Xinghao Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  18. 4.3.5 Guangdong Xinghao Pharmaceutical Co., Ltd. Recent Developments
  19. 4.4 Harbin Sanlian Pharmaceutical Co., Ltd.
  20. 4.4.1 Harbin Sanlian Pharmaceutical Co., Ltd. Company Information
  21. 4.4.2 Harbin Sanlian Pharmaceutical Co., Ltd. Business Overview
  22. 4.4.3 Harbin Sanlian Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Harbin Sanlian Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  24. 4.4.5 Harbin Sanlian Pharmaceutical Co., Ltd. Recent Developments
  25. 4.5 Harbin Songhe Pharmaceutical Co., Ltd.
  26. 4.5.1 Harbin Songhe Pharmaceutical Co., Ltd. Company Information
  27. 4.5.2 Harbin Songhe Pharmaceutical Co., Ltd. Business Overview
  28. 4.5.3 Harbin Songhe Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Harbin Songhe Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  30. 4.5.5 Harbin Songhe Pharmaceutical Co., Ltd. Recent Developments
  31. 4.6 Haikou Qili Pharmaceutical Co., Ltd.
  32. 4.6.1 Haikou Qili Pharmaceutical Co., Ltd. Company Information
  33. 4.6.2 Haikou Qili Pharmaceutical Co., Ltd. Business Overview
  34. 4.6.3 Haikou Qili Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Haikou Qili Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  36. 4.6.5 Haikou Qili Pharmaceutical Co., Ltd. Recent Developments
  37. 4.7 Hainan General Kangli Pharmaceutical Co., Ltd.
  38. 4.7.1 Hainan General Kangli Pharmaceutical Co., Ltd. Company Information
  39. 4.7.2 Hainan General Kangli Pharmaceutical Co., Ltd. Business Overview
  40. 4.7.3 Hainan General Kangli Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Hainan General Kangli Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  42. 4.7.5 Hainan General Kangli Pharmaceutical Co., Ltd. Recent Developments
  43. 4.8 Hainan Zhuotai Pharmaceutical Co., Ltd.
  44. 4.8.1 Hainan Zhuotai Pharmaceutical Co., Ltd. Company Information
  45. 4.8.2 Hainan Zhuotai Pharmaceutical Co., Ltd. Business Overview
  46. 4.8.3 Hainan Zhuotai Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Hainan Zhuotai Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  48. 4.8.5 Hainan Zhuotai Pharmaceutical Co., Ltd. Recent Developments
  49. 4.9 Hubei Wushi Pharmaceutical Co., Ltd.
  50. 4.9.1 Hubei Wushi Pharmaceutical Co., Ltd. Company Information
  51. 4.9.2 Hubei Wushi Pharmaceutical Co., Ltd. Business Overview
  52. 4.9.3 Hubei Wushi Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Hubei Wushi Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  54. 4.9.5 Hubei Wushi Pharmaceutical Co., Ltd. Recent Developments
  55. 4.10 Hunan Wuzhoutong Pharmaceutical Co., Ltd.
  56. 4.10.1 Hunan Wuzhoutong Pharmaceutical Co., Ltd. Company Information
  57. 4.10.2 Hunan Wuzhoutong Pharmaceutical Co., Ltd. Business Overview
  58. 4.10.3 Hunan Wuzhoutong Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Hunan Wuzhoutong Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  60. 4.10.5 Hunan Wuzhoutong Pharmaceutical Co., Ltd. Recent Developments
  61. 4.11 Hunan Yige Pharmaceutical Co., Ltd.
  62. 4.11.1 Hunan Yige Pharmaceutical Co., Ltd. Company Information
  63. 4.11.2 Hunan Yige Pharmaceutical Co., Ltd. Business Overview
  64. 4.11.3 Hunan Yige Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Hunan Yige Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  66. 4.11.5 Hunan Yige Pharmaceutical Co., Ltd. Recent Developments
  67. 4.12 Jiangxi Gannan Haixin Pharmaceutical Co., Ltd.
  68. 4.12.1 Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. Company Information
  69. 4.12.2 Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. Business Overview
  70. 4.12.3 Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  72. 4.12.5 Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. Recent Developments
  73. 4.13 Jincheng Haisi Pharmaceutical Co., Ltd.
  74. 4.13.1 Jincheng Haisi Pharmaceutical Co., Ltd. Company Information
  75. 4.13.2 Jincheng Haisi Pharmaceutical Co., Ltd. Business Overview
  76. 4.13.3 Jincheng Haisi Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Jincheng Haisi Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  78. 4.13.5 Jincheng Haisi Pharmaceutical Co., Ltd. Recent Developments
  79. 4.14 Ruiyang Pharmaceutical Co., Ltd.
  80. 4.14.1 Ruiyang Pharmaceutical Co., Ltd. Company Information
  81. 4.14.2 Ruiyang Pharmaceutical Co., Ltd. Business Overview
  82. 4.14.3 Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Ruiyang Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  84. 4.14.5 Ruiyang Pharmaceutical Co., Ltd. Recent Developments
  85. 4.15 Shandong Phoenix Pharmaceutical Co., Ltd.
  86. 4.15.1 Shandong Phoenix Pharmaceutical Co., Ltd. Company Information
  87. 4.15.2 Shandong Phoenix Pharmaceutical Co., Ltd. Business Overview
  88. 4.15.3 Shandong Phoenix Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Shandong Phoenix Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  90. 4.15.5 Shandong Phoenix Pharmaceutical Co., Ltd. Recent Developments
  91. 4.16 Sichuan Sanxingdui Pharmaceutical Co., Ltd.
  92. 4.16.1 Sichuan Sanxingdui Pharmaceutical Co., Ltd. Company Information
  93. 4.16.2 Sichuan Sanxingdui Pharmaceutical Co., Ltd. Business Overview
  94. 4.16.3 Sichuan Sanxingdui Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Sichuan Sanxingdui Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  96. 4.16.5 Sichuan Sanxingdui Pharmaceutical Co., Ltd. Recent Developments
  97. 4.17 Yantai Dongcheng North Pharmaceutical Co., Ltd.
  98. 4.17.1 Yantai Dongcheng North Pharmaceutical Co., Ltd. Company Information
  99. 4.17.2 Yantai Dongcheng North Pharmaceutical Co., Ltd. Business Overview
  100. 4.17.3 Yantai Dongcheng North Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Yantai Dongcheng North Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  102. 4.17.5 Yantai Dongcheng North Pharmaceutical Co., Ltd. Recent Developments
  103. 4.18 Zhejiang Beide Pharmaceutical Co., Ltd.
  104. 4.18.1 Zhejiang Beide Pharmaceutical Co., Ltd. Company Information
  105. 4.18.2 Zhejiang Beide Pharmaceutical Co., Ltd. Business Overview
  106. 4.18.3 Zhejiang Beide Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Zhejiang Beide Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  108. 4.18.5 Zhejiang Beide Pharmaceutical Co., Ltd. Recent Developments
  109. 4.19 Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
  110. 4.19.1 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Company Information
  111. 4.19.2 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Business Overview
  112. 4.19.3 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  114. 4.19.5 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Recent Developments
  115. 4.20 Zhejiang Zuoli Pharmaceutical Co., Ltd.
  116. 4.20.1 Zhejiang Zuoli Pharmaceutical Co., Ltd. Company Information
  117. 4.20.2 Zhejiang Zuoli Pharmaceutical Co., Ltd. Business Overview
  118. 4.20.3 Zhejiang Zuoli Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Zhejiang Zuoli Pharmaceutical Co., Ltd. Pefloxacin Mesylate for Injection Product Portfolio
  120. 4.20.5 Zhejiang Zuoli Pharmaceutical Co., Ltd. Recent Developments
5 Global Pefloxacin Mesylate for Injection Market Scenario by Region
  1. 5.1 Global Pefloxacin Mesylate for Injection Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Pefloxacin Mesylate for Injection Sales by Region: 2021-2032
  3. 5.2.1 Global Pefloxacin Mesylate for Injection Sales by Region: 2021-2026
  4. 5.2.2 Global Pefloxacin Mesylate for Injection Sales by Region: 2027-2032
  5. 5.3 Global Pefloxacin Mesylate for Injection Revenue by Region: 2021-2032
  6. 5.3.1 Global Pefloxacin Mesylate for Injection Revenue by Region: 2021-2026
  7. 5.3.2 Global Pefloxacin Mesylate for Injection Revenue by Region: 2027-2032
  8. 5.4 North America Pefloxacin Mesylate for Injection Market Facts & Figures by Country
  9. 5.4.1 North America Pefloxacin Mesylate for Injection Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Pefloxacin Mesylate for Injection Sales by Country (2021-2032)
  11. 5.4.3 North America Pefloxacin Mesylate for Injection Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Pefloxacin Mesylate for Injection Market Facts & Figures by Country
  16. 5.5.1 Europe Pefloxacin Mesylate for Injection Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Pefloxacin Mesylate for Injection Sales by Country (2021-2032)
  18. 5.5.3 Europe Pefloxacin Mesylate for Injection Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Pefloxacin Mesylate for Injection Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Pefloxacin Mesylate for Injection Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Pefloxacin Mesylate for Injection Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Pefloxacin Mesylate for Injection Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Pefloxacin Mesylate for Injection Market Facts & Figures by Country
  41. 5.7.1 South America Pefloxacin Mesylate for Injection Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Pefloxacin Mesylate for Injection Sales by Country (2021-2032)
  43. 5.7.3 South America Pefloxacin Mesylate for Injection Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Pefloxacin Mesylate for Injection Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Pefloxacin Mesylate for Injection Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Pefloxacin Mesylate for Injection Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Pefloxacin Mesylate for Injection Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Pefloxacin Mesylate for Injection Sales by Type (2021-2032)
  2. 6.1.1 Global Pefloxacin Mesylate for Injection Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Pefloxacin Mesylate for Injection Sales Market Share by Type (2021-2032)
  4. 6.2 Global Pefloxacin Mesylate for Injection Revenue by Type (2021-2032)
  5. 6.2.1 Global Pefloxacin Mesylate for Injection Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Pefloxacin Mesylate for Injection Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Pefloxacin Mesylate for Injection Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Pefloxacin Mesylate for Injection Sales by Application (2021-2032)
  2. 7.1.1 Global Pefloxacin Mesylate for Injection Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Pefloxacin Mesylate for Injection Sales Market Share by Application (2021-2032)
  4. 7.2 Global Pefloxacin Mesylate for Injection Revenue by Application (2021-2032)
  5. 7.2.1 Global Pefloxacin Mesylate for Injection Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Pefloxacin Mesylate for Injection Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Pefloxacin Mesylate for Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Pefloxacin Mesylate for Injection Value Chain Analysis
  2. 8.1.1 Pefloxacin Mesylate for Injection Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Pefloxacin Mesylate for Injection Production Mode & Process
  5. 8.2 Pefloxacin Mesylate for Injection Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Pefloxacin Mesylate for Injection Distributors
  8. 8.2.3 Pefloxacin Mesylate for Injection Customers
9 Global Pefloxacin Mesylate for Injection Analyzing Market Dynamics
  1. 9.1 Pefloxacin Mesylate for Injection Industry Trends
  2. 9.2 Pefloxacin Mesylate for Injection Industry Drivers
  3. 9.3 Pefloxacin Mesylate for Injection Industry Opportunities and Challenges
  4. 9.4 Pefloxacin Mesylate for Injection Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst